Pharmacological adjuvants for diabetic vitrectomy surgery

doi:10.5662/wjm.v14.i4.92246

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1343)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

HTML

970

Tables (1-1)

187

Sum=1191

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=116

Dec 20, 2024 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Methodol. Dec 20, 2024; 14(4): 92246
Published online Dec 20, 2024. doi: 10.5662/wjm.v14.i4.92246

Pharmacological adjuvants for diabetic vitrectomy surgery

Ramesh Venkatesh, Chaitra Jayadev, Vishma Prabhu, Priyanka Gandhi, Rupal Kathare, Naresh K Yadav, Ayushi Choudhary, Jay Chhablani

Ramesh Venkatesh, Department of Ophthalmology, Narayana Nethralaya, Bangalore 560010, India

Chaitra Jayadev, Vishma Prabhu, Priyanka Gandhi, Rupal Kathare, Ayushi Choudhary, Department of Retina, Narayana Nethralaya Eye Institute, Bangalore 560010, India

Naresh K Yadav, Department of Vitreo Retina, Narayana Nethralaya, Retina Serv, Super Specialty Eye Hospital and Post Graduate Institute of Ophthalmology, Bangalore 560010, India

Jay Chhablani, Department of Retina, University of Pittsburg School of Medicine, Pittsburg, PA 15213, United States

Author contributions: Venkatesh R writing, critical review and revising the manuscript; Jayadev C, Prabhu V, Yadav NK reviewing the manuscript; Gandhi P, Kathare R, Choudhary A assisting in writing the manuscript; Chhablani J critical review of the manuscript.

Conflict-of-interest statement: None of the authors have anything to declare.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ramesh Venkatesh, MBBS, MD, MS, Doctor, Surgeon, Department of Ophthalmology, Narayana Nethralaya, 121/C. 1^st R block, West of Chord Road, Rajaji Nagar, Bangalore 560010, India. vramesh80@yahoo.com

Received: January 20, 2024
Revised: June 26, 2024
Accepted: July 5, 2024
Published online: December 20, 2024
Processing time: 188 Days and 6.9 Hours

Core Tip

Core Tip: For advanced diabetic retinopathy, diabetic vitrectomy is a complex procedure with unpredictable outcomes. In the last decade, intravitreal pharmacotherapy has advanced, providing new ways to improve surgical outcomes for our patients. In medicine, an "adjunct" refers to a drug or substance that supplements the main treatment. This review will look at the pharmacological adjuncts used in diabetic vitrectomy surgery and how they affect specific steps. The categorization system enables surgeons to anticipate surgical issues and select the appropriate pharmacological agent to address them, thereby increasing surgical success rates.